Results 21 to 30 of about 82,677 (285)

Carbon dioxide angiography during peripheral angioplasty procedures significantly reduces the risk of contrast-induced nephropathy in patients with chronic kidney disease

open access: yesCVIR Endovascular, 2020
Background Iodinated contrast media are amongst the most frequently prescribed medications, however, their use is not without complications. With contrast-induced nephropathy constituting a major concern, alternative non-iodine based approaches have been
Athanasios Diamantopoulos   +10 more
doaj   +1 more source

Repurposing Statins for Renal Protection: Is It a Class Effect? [PDF]

open access: yes, 2017
There has been a great deal of excitement regarding the potential benefits of statins beyond their lipid-lowering effect, and repurposing them for other indications.
Antoine, Daniel J   +2 more
core   +1 more source

Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases [PDF]

open access: yes, 2016
Purpose of review: Urine is the most useful of body fluids for biomarker research. Therefore, we have focused on urinary proteomics, using capillary electrophoresis coupled to mass spectrometry, to investigate kidney diseases in recent years.
Magalhães, Pedro   +2 more
core   +1 more source

Contrast induced nephropathy: Pathophysiology and prevention

open access: yesHeart India, 2013
The steadily increasing use of contrast media in radiological and interventional cardiac procedures has led to more research and well designed studies of prophylactic strategies for its leading life threatening side effect of contrast induced nephropathy
Sudarshan Kumar Vijay   +2 more
doaj   +1 more source

Miscellanea. Folyóirat-referátumok. OH-KVÍZ. [PDF]

open access: yes, 2016
Kardiológia A gyulladás és a korai nagy dózisú rosuvastatinkezelés kapcsolata kontrasztanyag által indukált nephropathiában szenvedő akut coronariaszindrómás betegeknél: a PRATO-ACS vizsgálatban észlelt kórélettani kapcsolat [Relationship ...
Fischer, Tamás, Ábel, Tatjána
core   +1 more source

SGLT2 Inhibitors and the Diabetic Kidney [PDF]

open access: yes, 2016
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease worldwide. Blood glucose and blood pressure control reduce the risk of developing this complication; however, once DN is established, it is only possible to slow progression ...
Busetto, Luca   +4 more
core   +1 more source

Sphingosine 1-phosphate in renal diseases [PDF]

open access: yes, 2013
Because of its highly bioactive properties sphingosine 1-phosphate (S1P) is an attractive target for the treatment of several diseases. Since the expression of sphingosine kinases as well as S1P receptors was demonstrated in the kidney, questions about ...
Huwiler, Andrea   +2 more
core   +2 more sources

Inhibiting ERK Activation with CI-1040 Leads to Compensatory Upregulation of Alternate MAPKs and Plasminogen Activator Inhibitor-1 following Subtotal Nephrectomy with No Impact on Kidney Fibrosis [PDF]

open access: yes, 2015
Extracellular-signal regulated kinase (ERK) activation by MEK plays a key role in many of the cellular processes that underlie progressive kidney fibrosis including cell proliferation, apoptosis and transforming growth factor β1-mediated epithelial to ...
AA Eddy   +50 more
core   +6 more sources

Contrast Induced Nephropathy in ICU settings

open access: yesJournal of Pediatric Critical Care, 2018
Contrast-Induced Nephropathy (CIN) is defined as acute deterioration of renal function after the administration of Radio-contrast materials, mostly within a period of 24 to 48 hours.
Raghavendra Vanaki
doaj   +1 more source

Experimental rat models of chronic allograft nephropathy: a review [PDF]

open access: yes, 2014
Chronic allograft nephropathy (CAN) is the leading cause of late allograft loss after renal transplantation (RT), which continues to remain an unresolved problem. A rat model of CAN was first described in 1969 by White et al. Although the rat model of RT
Haylor, John, Shrestha, Badri
core   +2 more sources

Home - About - Disclaimer - Privacy